{"id":21202,"date":"2020-01-15T04:58:38","date_gmt":"2020-01-15T09:58:38","guid":{"rendered":"https:\/\/blogs.funiber.org\/pt\/?p=21202"},"modified":"2020-01-15T04:58:38","modified_gmt":"2020-01-15T09:58:38","slug":"funiber-alzheimer-avancos","status":"publish","type":"post","link":"https:\/\/www.funiber.blog\/pt\/gerontologia\/2020\/01\/15\/funiber-alzheimer-avancos","title":{"rendered":"Novos avan\u00e7os para retardar a doen\u00e7a de Alzheimer"},"content":{"rendered":"<h2><strong>A empresa espanhola Grifols, especializada no setor farmac\u00eautico e hospitalar, apresentou neste m\u00eas novos dados sobre seu ensaio cl\u00ednico AMBAR<\/strong><\/h2>\n<p>A empresa catal\u00e3 <a href=\"https:\/\/www.grifols.com\/es\/home\" target=\"_blank\" rel=\"noopener noreferrer\">Grifols<\/a> apresentou no in\u00edcio de dezembro os novos dados que completam seu ensaio cl\u00ednico <a href=\"https:\/\/www.grifols.com\/es\/ambar\" target=\"_blank\" rel=\"noopener noreferrer\">AMBAR (Alzheimer Management by Albumin Replacement)<\/a>, uma terapia para combater a doen\u00e7a de Alzheimer, no \u00e2mbito da realiza\u00e7\u00e3o da <a href=\"https:\/\/www.ctad-alzheimer.com\" target=\"_blank\" rel=\"noopener noreferrer\">Conferencia Clinical trial on Alzheimer\u2019s Disease (CTAD<\/a> em San Diego, Calif\u00f3rnia (Estados Unidos).<!--more--><\/p>\n<p>Os dados confirmam os resultados positivos dos testes subsequentes, confirmando o efeito positivo das prote\u00ednas plasm\u00e1ticas para retardar a progress\u00e3o da referida doen\u00e7a neurodegenerativa. Esses novos dados refor\u00e7am o compromisso da empresa de expandir o mercado potencial de derivados de plasma, at\u00e9 agora utilizado principalmente no tratamento de doen\u00e7as minorit\u00e1rias.<\/p>\n<p>O ensaio cl\u00ednico, que teve a participa\u00e7\u00e3o de quase 500 pacientes entre 55 e 58 anos, que sofrem da doen\u00e7a em est\u00e1gio leve e moderado, reflete como &#8220;a redu\u00e7\u00e3o do metabolismo da glicose cerebral associada \u00e0 doen\u00e7a&#8221; \u00e9 retardada, reflete o jornal espanhol La Vanguardia. O diretor do programa cl\u00ednico da AMBAR, Dr. Antonio Pa\u00e9z, apresentou algumas imagens que evidenciaram esse progresso depois que os pacientes foram submetidos a uma troca plasm\u00e1tica.<\/p>\n<p>Frear a doen\u00e7a de Alzheimer e outras doen\u00e7as neurodegenerativas \u00e9 o objetivo dos especialistas m\u00e9dicos na terceira idade. Todos os profissionais que desejam ampliar sua forma\u00e7\u00e3o nesse campo podem faz\u00ea-lo por meio dos programas universit\u00e1rios patrocinados pela <a href=\"https:\/\/www.funiber.org.br\/\" target=\"_blank\" rel=\"noopener noreferrer\">FUNIBER<\/a>, como, por exemplo, o <a href=\"https:\/\/www.funiber.org.br\/mestrados-saude-e-nutricao\/gerontologia\" target=\"_blank\" rel=\"noopener noreferrer\">Mestrado em Gerontologia<\/a>.<\/p>\n<p>Fontes: <a href=\"https:\/\/www.efe.com\/efe\/espana\/efeempresas\/grifols-confirma-la-eficacia-de-su-terapia-contra-el-alzheimer\/50000908-4127376\" target=\"_blank\" rel=\"noopener noreferrer\">Grifols confirma la eficacia de su terapia contra el alzheimer<\/a>.<\/p>\n<p><a href=\"https:\/\/www.lavanguardia.com\/economia\/20191207\/472078118485\/grifols-alzheimer-albumina-exito.html\" target=\"_blank\" rel=\"noopener noreferrer\">Grifols refuerza su apuesta contra el alzheimer con nuevos datos<\/a>.<\/p>\n<p>Foto: Todos os direitos reservados.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A empresa espanhola Grifols, especializada no setor farmac\u00eautico e hospitalar, apresentou neste m\u00eas novos dados sobre seu ensaio cl\u00ednico AMBAR A empresa catal\u00e3 Grifols apresentou no in\u00edcio de dezembro os novos dados que completam seu ensaio cl\u00ednico AMBAR (Alzheimer Management by Albumin Replacement), uma terapia para combater a doen\u00e7a de Alzheimer, no \u00e2mbito da realiza\u00e7\u00e3o [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":21203,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_newsletter_tier_id":0,"footnotes":"","jetpack_publicize_message":"","jetpack_is_tweetstorm":false,"jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false}}},"categories":[1],"tags":[108,1242,122,855,100,119,4300,911,739,671,641,255,266,113,217],"jetpack_publicize_connections":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Novos avan\u00e7os para retardar a doen\u00e7a de Alzheimer<\/title>\n<meta name=\"description\" content=\"A empresa espanhola Grifols, especializada no setor farmac\u00eautico e hospitalar, apresentou neste m\u00eas novos dados sobre seu ensaio cl\u00ednico AMBAR\" \/>\n<meta name=\"robots\" content=\"noindex, nofollow\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novos avan\u00e7os para retardar a doen\u00e7a de Alzheimer\" \/>\n<meta property=\"og:description\" content=\"A empresa espanhola Grifols, especializada no setor farmac\u00eautico e hospitalar, apresentou neste m\u00eas novos dados sobre seu ensaio cl\u00ednico AMBAR\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.funiber.org\/pt\/gerontologia\/2020\/01\/15\/funiber-alzheimer-avancos\" \/>\n<meta property=\"og:site_name\" content=\"FuniBlogs - FUNIBER\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/funiber\" \/>\n<meta property=\"article:published_time\" content=\"2020-01-15T09:58:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.funiber.org\/pt\/wp-content\/uploads\/2020\/01\/funiber-alzheimer-avancos.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"587\" \/>\n\t<meta property=\"og:image:height\" content=\"392\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Michelle\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@FUNIBER\" \/>\n<meta name=\"twitter:site\" content=\"@FUNIBER\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Michelle\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/blogs.funiber.org\/pt\/gerontologia\/2020\/01\/15\/funiber-alzheimer-avancos#article\",\"isPartOf\":{\"@id\":\"https:\/\/blogs.funiber.org\/pt\/gerontologia\/2020\/01\/15\/funiber-alzheimer-avancos\"},\"author\":{\"name\":\"Michelle\",\"@id\":\"https:\/\/blogs.funiber.org\/pt\/#\/schema\/person\/a1eaaa5e57eac866a8c5946946bcf80d\"},\"headline\":\"Novos avan\u00e7os para retardar a doen\u00e7a de Alzheimer\",\"datePublished\":\"2020-01-15T09:58:38+00:00\",\"dateModified\":\"2020-01-15T09:58:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/blogs.funiber.org\/pt\/gerontologia\/2020\/01\/15\/funiber-alzheimer-avancos\"},\"wordCount\":297,\"publisher\":{\"@id\":\"https:\/\/blogs.funiber.org\/pt\/#organization\"},\"keywords\":[\"Alzheimer\",\"Bolsas\",\"Doen\u00e7as\",\"Doutorado\",\"Envelhecimento\",\"Estudos\",\"farm\u00e1cia\",\"FUNIBER Opini\u00f5es\",\"gerontologia\",\"mestrado\",\"Opini\u00e3o FUNIBER\",\"Opini\u00f5es Funiber\",\"Pesquisas\",\"Sa\u00fade\",\"Terceira idade\"],\"articleSection\":[\"Gerontologia\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/blogs.funiber.org\/pt\/gerontologia\/2020\/01\/15\/funiber-alzheimer-avancos\",\"url\":\"https:\/\/blogs.funiber.org\/pt\/gerontologia\/2020\/01\/15\/funiber-alzheimer-avancos\",\"name\":\"Novos avan\u00e7os para retardar a doen\u00e7a de Alzheimer\",\"isPartOf\":{\"@id\":\"https:\/\/blogs.funiber.org\/pt\/#website\"},\"datePublished\":\"2020-01-15T09:58:38+00:00\",\"dateModified\":\"2020-01-15T09:58:38+00:00\",\"description\":\"A empresa espanhola Grifols, especializada no setor farmac\u00eautico e hospitalar, apresentou neste m\u00eas novos dados sobre seu ensaio cl\u00ednico AMBAR\",\"breadcrumb\":{\"@id\":\"https:\/\/blogs.funiber.org\/pt\/gerontologia\/2020\/01\/15\/funiber-alzheimer-avancos#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/blogs.funiber.org\/pt\/gerontologia\/2020\/01\/15\/funiber-alzheimer-avancos\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/blogs.funiber.org\/pt\/gerontologia\/2020\/01\/15\/funiber-alzheimer-avancos#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/blogs.funiber.org\/pt\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novos avan\u00e7os para retardar a doen\u00e7a de Alzheimer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/blogs.funiber.org\/pt\/#website\",\"url\":\"https:\/\/blogs.funiber.org\/pt\/\",\"name\":\"FuniBlogs - FUNIBER\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/blogs.funiber.org\/pt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/blogs.funiber.org\/pt\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/blogs.funiber.org\/pt\/#organization\",\"name\":\"FuniBlogs - FUNIBER\",\"url\":\"https:\/\/blogs.funiber.org\/pt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/blogs.funiber.org\/pt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.funiber.blog\/pt\/wp-content\/uploads\/2022\/02\/logo-funiber-pt-br-v-dos.svg\",\"contentUrl\":\"https:\/\/www.funiber.blog\/pt\/wp-content\/uploads\/2022\/02\/logo-funiber-pt-br-v-dos.svg\",\"width\":1,\"height\":1,\"caption\":\"FuniBlogs - FUNIBER\"},\"image\":{\"@id\":\"https:\/\/blogs.funiber.org\/pt\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/funiber\",\"https:\/\/twitter.com\/FUNIBER\",\"https:\/\/www.instagram.com\/funiber_becas\",\"https:\/\/www.youtube.com\/user\/funiber\",\"https:\/\/www.linkedin.com\/company\/funiber\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/blogs.funiber.org\/pt\/#\/schema\/person\/a1eaaa5e57eac866a8c5946946bcf80d\",\"name\":\"Michelle\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/blogs.funiber.org\/pt\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5e87041f7609dc50493cf216754fece1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5e87041f7609dc50493cf216754fece1?s=96&d=mm&r=g\",\"caption\":\"Michelle\"},\"url\":\"https:\/\/www.funiber.blog\/pt\/author\/michelle-moreira\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novos avan\u00e7os para retardar a doen\u00e7a de Alzheimer","description":"A empresa espanhola Grifols, especializada no setor farmac\u00eautico e hospitalar, apresentou neste m\u00eas novos dados sobre seu ensaio cl\u00ednico AMBAR","robots":{"index":"noindex","follow":"nofollow"},"og_locale":"pt_BR","og_type":"article","og_title":"Novos avan\u00e7os para retardar a doen\u00e7a de Alzheimer","og_description":"A empresa espanhola Grifols, especializada no setor farmac\u00eautico e hospitalar, apresentou neste m\u00eas novos dados sobre seu ensaio cl\u00ednico AMBAR","og_url":"https:\/\/blogs.funiber.org\/pt\/gerontologia\/2020\/01\/15\/funiber-alzheimer-avancos","og_site_name":"FuniBlogs - FUNIBER","article_publisher":"https:\/\/www.facebook.com\/funiber","article_published_time":"2020-01-15T09:58:38+00:00","og_image":[{"width":587,"height":392,"url":"https:\/\/blogs.funiber.org\/pt\/wp-content\/uploads\/2020\/01\/funiber-alzheimer-avancos.jpg","type":"image\/jpeg"}],"author":"Michelle","twitter_card":"summary_large_image","twitter_creator":"@FUNIBER","twitter_site":"@FUNIBER","twitter_misc":{"Escrito por":"Michelle","Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.funiber.org\/pt\/gerontologia\/2020\/01\/15\/funiber-alzheimer-avancos#article","isPartOf":{"@id":"https:\/\/blogs.funiber.org\/pt\/gerontologia\/2020\/01\/15\/funiber-alzheimer-avancos"},"author":{"name":"Michelle","@id":"https:\/\/blogs.funiber.org\/pt\/#\/schema\/person\/a1eaaa5e57eac866a8c5946946bcf80d"},"headline":"Novos avan\u00e7os para retardar a doen\u00e7a de Alzheimer","datePublished":"2020-01-15T09:58:38+00:00","dateModified":"2020-01-15T09:58:38+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.funiber.org\/pt\/gerontologia\/2020\/01\/15\/funiber-alzheimer-avancos"},"wordCount":297,"publisher":{"@id":"https:\/\/blogs.funiber.org\/pt\/#organization"},"keywords":["Alzheimer","Bolsas","Doen\u00e7as","Doutorado","Envelhecimento","Estudos","farm\u00e1cia","FUNIBER Opini\u00f5es","gerontologia","mestrado","Opini\u00e3o FUNIBER","Opini\u00f5es Funiber","Pesquisas","Sa\u00fade","Terceira idade"],"articleSection":["Gerontologia"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/blogs.funiber.org\/pt\/gerontologia\/2020\/01\/15\/funiber-alzheimer-avancos","url":"https:\/\/blogs.funiber.org\/pt\/gerontologia\/2020\/01\/15\/funiber-alzheimer-avancos","name":"Novos avan\u00e7os para retardar a doen\u00e7a de Alzheimer","isPartOf":{"@id":"https:\/\/blogs.funiber.org\/pt\/#website"},"datePublished":"2020-01-15T09:58:38+00:00","dateModified":"2020-01-15T09:58:38+00:00","description":"A empresa espanhola Grifols, especializada no setor farmac\u00eautico e hospitalar, apresentou neste m\u00eas novos dados sobre seu ensaio cl\u00ednico AMBAR","breadcrumb":{"@id":"https:\/\/blogs.funiber.org\/pt\/gerontologia\/2020\/01\/15\/funiber-alzheimer-avancos#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.funiber.org\/pt\/gerontologia\/2020\/01\/15\/funiber-alzheimer-avancos"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.funiber.org\/pt\/gerontologia\/2020\/01\/15\/funiber-alzheimer-avancos#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/blogs.funiber.org\/pt"},{"@type":"ListItem","position":2,"name":"Novos avan\u00e7os para retardar a doen\u00e7a de Alzheimer"}]},{"@type":"WebSite","@id":"https:\/\/blogs.funiber.org\/pt\/#website","url":"https:\/\/blogs.funiber.org\/pt\/","name":"FuniBlogs - FUNIBER","description":"","publisher":{"@id":"https:\/\/blogs.funiber.org\/pt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.funiber.org\/pt\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/blogs.funiber.org\/pt\/#organization","name":"FuniBlogs - FUNIBER","url":"https:\/\/blogs.funiber.org\/pt\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/blogs.funiber.org\/pt\/#\/schema\/logo\/image\/","url":"https:\/\/www.funiber.blog\/pt\/wp-content\/uploads\/2022\/02\/logo-funiber-pt-br-v-dos.svg","contentUrl":"https:\/\/www.funiber.blog\/pt\/wp-content\/uploads\/2022\/02\/logo-funiber-pt-br-v-dos.svg","width":1,"height":1,"caption":"FuniBlogs - FUNIBER"},"image":{"@id":"https:\/\/blogs.funiber.org\/pt\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/funiber","https:\/\/twitter.com\/FUNIBER","https:\/\/www.instagram.com\/funiber_becas","https:\/\/www.youtube.com\/user\/funiber","https:\/\/www.linkedin.com\/company\/funiber"]},{"@type":"Person","@id":"https:\/\/blogs.funiber.org\/pt\/#\/schema\/person\/a1eaaa5e57eac866a8c5946946bcf80d","name":"Michelle","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/blogs.funiber.org\/pt\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5e87041f7609dc50493cf216754fece1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5e87041f7609dc50493cf216754fece1?s=96&d=mm&r=g","caption":"Michelle"},"url":"https:\/\/www.funiber.blog\/pt\/author\/michelle-moreira"}]}},"jetpack_featured_media_url":"https:\/\/www.funiber.blog\/pt\/wp-content\/uploads\/2020\/01\/funiber-alzheimer-avancos.jpg","jetpack_shortlink":"https:\/\/wp.me\/p7ee1t-5vY","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.funiber.blog\/pt\/wp-json\/wp\/v2\/posts\/21202"}],"collection":[{"href":"https:\/\/www.funiber.blog\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.funiber.blog\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.funiber.blog\/pt\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.funiber.blog\/pt\/wp-json\/wp\/v2\/comments?post=21202"}],"version-history":[{"count":1,"href":"https:\/\/www.funiber.blog\/pt\/wp-json\/wp\/v2\/posts\/21202\/revisions"}],"predecessor-version":[{"id":21204,"href":"https:\/\/www.funiber.blog\/pt\/wp-json\/wp\/v2\/posts\/21202\/revisions\/21204"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.funiber.blog\/pt\/wp-json\/wp\/v2\/media\/21203"}],"wp:attachment":[{"href":"https:\/\/www.funiber.blog\/pt\/wp-json\/wp\/v2\/media?parent=21202"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.funiber.blog\/pt\/wp-json\/wp\/v2\/categories?post=21202"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.funiber.blog\/pt\/wp-json\/wp\/v2\/tags?post=21202"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}